In publicly available genomewide gene expression data, CALCRL was upregulated in LSC-enriched versus LSC-depleted AML cell populations and in LSC-versus HSC-enriched cell populations and was an independent prognostic parameter for poor outcome in several AML cohorts [74] (Figure 2). The gene discussed is CALCRL; the disease is acute myeloid leukemia.